Evidence map›Paper›PMID 17699580›Full record

ArticleJournal of virology2007

Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation.

Jonah B Sacha, Chungwon Chung, Jason Reed, Anna K Jonas, Alexander T Bean, Sean P Spencer, Wonhee Lee, Lara Vojnov, Richard Rudersdorf, Thomas C Friedrich and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 58 citations in OpenAlex.

  1. HLA-B*14:02-Restricted Env-Specific CD8Journal of virology · 2017
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Role of HIV-specific CD8The Journal of experimental medicine · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Jonah B SachaDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 555 Science Drive, Madison, WI 53711, USA.
Chungwon Chung
Jason Reed
Anna K Jonas
Alexander T Bean
Sean P Spencer
Wonhee Lee
Lara Vojnov
Richard Rudersdorf
Thomas C Friedrich
Nancy A Wilson
Jeffrey D Lifson
David I Watkins
University of Wisconsin–Madison · USNational Cancer Institute · US

Funding

SEA Influenza Clinical Research NetworkN01CO12400 · NCI · LEIDOS BIOMEDICAL RESEARCH, INC. · 2007 to 2008
$225.2M
ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
The Functional Significance of Cytotoxic T Lymphocyte EscapeR01AI052056 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2003 to 2024
$8.3M
MHC-bound, SIV-derived, CTL &HTL EpitopesR24RR015371 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2000 to 2011
$8.1M
A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENTR01AI049120 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2001 to 2009
$7.6M
EXTRAMURAL RES FACIL CONST: REPRODUCTIVE, GROWTH &DVMT, MENOPAUSEC06RR020141 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2004 to 2004
$3.6M
EXTRAMURAL REGIONAL FACILITIES CONSTRUCTIONC06RR015459 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2000 to 2000
$1.9M
NCI NIH HHS N01 CO012400NCI NIH HHS N01 CO 12400NCRR NIH HHS C06 RR015459NCRR NIH HHS C06 RR020141NCRR NIH HHS P51 RR 000167NCRR NIH HHS P51 RR000167NCRR NIH HHS R24 RR 015371NCRR NIH HHS R24 RR015371NCRR NIH HHS RR 020141-01NCRR NIH HHS RR 15459-01NIAID NIH HHS R01 AI 049120NIAID NIH HHS R01 AI049120NIAID NIH HHS R01 AI 052056NIAID NIH HHS R01 AI052056
6 · The paper itself

Abstract

Effective, vaccine-induced CD8+ T-cell responses should recognize infected cells early enough to prevent production of progeny virions. We have recently shown that Gag-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells at 2 h postinfection, whereas Env-specific CD8+ T cells do not recognize infected cells until much later in infection. However, it remains unknown when other proteins present in the viral particle are presented to CD8+ T cells after infection. To address this issue, we explored CD8+ T-cell recognition of epitopes derived from two other relatively large virion proteins, Pol and Nef. Surprisingly, infected cells efficiently presented CD8+ T-cell epitopes from virion-derived Pol proteins within 2 h of infection. In contrast, Nef-specific CD8+ T cells did not recognize infected cells until 12 h postinfection. Additionally, we show that SIVmac239 Nef downregulated surface major histocompatibility complex class I (MHC-I) molecules beginning at 12 h postinfection, concomitant with presentation of Nef-derived CD8+ T-cell epitopes. Finally, Pol-specific CD8+ T cells eliminated infected cells as early as 6 h postinfection, well before MHC-I downregulation, suggesting a previously underappreciated antiviral role for Pol-specific CD8+ T cells.

Indexed as

Gene Expression Regulation, ViralAnimalsCD8-Positive T-LymphocytesCells, CulturedDown-RegulationEpitopesEpitopes, T-LymphocyteGene Products, polHistocompatibility Antigens Class IMacaca mulattaMajor Histocompatibility ComplexSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusTime FactorsViral Regulatory and Accessory ProteinsEpitopesEpitopes, T-LymphocyteGene Products, polHistocompatibility Antigens Class INEF protein, SIVViral Regulatory and Accessory Proteins

Identifiers

PMID17699580
PMCPMC2168778
OpenAlexW2100600596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.